trending Market Intelligence /marketintelligence/en/news-insights/trending/MNvTtpbNUxKN9Z6PPamreQ2 content esgSubNav
Log in to other products


Looking for more?

Contact Us
In This List

Ascletis Pharma director resigns


Climate Credit Analytics: Linking climate scenarios to financial impacts


Global M&A Infographic Q1 2021


Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge


COVID-19 Impact & Recovery: Private Equity

Ascletis Pharma director resigns

Ascletis Pharma Inc. said Wei Fu resigned from the board as a nonexecutive director on Dec. 24 due to other business commitments.

The company said Fu has no disagreement with the board.

China's Ascletis Pharma is an investment holding company that focuses on the development and commercialization of various drugs.